Sodium valproate is a commonly used anticonvulsant. It is widely recognized that valproate can cause hyperammonemia, particularly in people with underlying liver disease. Patients with urea cycle disorders are...
https://ift.tt/2rQFciA
Πέμπτη 17 Μαΐου 2018
Valproate-induced hyperammonemia - uncovering an underlying inherited metabolic disorder: a case report
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου